Treatment of mucocutaneous candidasis with transfer factor.
D000666:Amphotericin B / Q000627:therapeutic use; D000942:Antigens, Bacterial; D002179:Candidiasis, Cutaneous / Q000188:drug therapy* / Q000276:immunology; D002675:Child, Preschool; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D006968:Hypersensitivity, Delayed; D007112:Immunity, Maternally-Acquired; D007074:Immunoglobulin G; D007223:Infant; D037102:Lectins; D007962:Leukocytes / Q000201:enzymology; D008214:Lymphocytes / Q000276:immunology / Q000378:metabolism; D008222:Lymphokines / Q000627:therapeutic use*; D008263:Macrophage Migration-Inhibitory Factors / Q000096:biosynthesis; D008297:Male; D010544:Peroxidases / Q000378:metabolism; D011955:Receptors, Drug; D012075:Remission, Spontaneous; D013997:Time Factors
D000942:Antigens, Bacterial; D007074:Immunoglobulin G; D037102:Lectins; D008222:Lymphokines; D008263:Macrophage Migration-Inhibitory Factors; D011955:Receptors, Drug; D000666:Amphotericin B; D005437:Flucytosine; D010544:Peroxidases